Alto Neuroscience, Stock Price on November 4, 2024

ANRO Stock   4.31  0.22  5.38%   
If you're considering investing in Alto Stock, it is important to understand the factors that can impact its price. As of today, the current price of Alto Neuroscience, stands at 4.31, as last reported on the 25th of November, with the highest price reaching 4.43 and the lowest price hitting 4.10 during the day. Alto Neuroscience, secures Sharpe Ratio (or Efficiency) of -0.0682, which signifies that the company had a -0.0682% return per unit of risk over the last 3 months. Alto Neuroscience, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alto Neuroscience,'s Mean Deviation of 4.76, standard deviation of 9.89, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide.
  
As of the 25th of November 2024, Other Stockholder Equity is likely to grow to about 6.5 M, while Total Stockholder Equity is likely to drop (67.7 M). . As of the 25th of November 2024, Price To Sales Ratio is likely to drop to 2,017. In addition to that, Price Earnings Ratio is likely to drop to -16.09. Alto Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0682

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsANRO

Estimated Market Risk

 9.99
  actual daily
88
88% of assets are less volatile

Expected Return

 -0.68
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Alto Neuroscience, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alto Neuroscience, by adding Alto Neuroscience, to a well-diversified portfolio.
Price Book
2.0424
Book Value
6.671
Enterprise Value
184.1 M
Shares Float
19.4 M
Shares Outstanding
27 M

Alto Neuroscience, Main Headline on 4th of November 2024

NEW YORK, NY ACCESSWIRE November 4, 2024 Levi Korsinsky notifies investors that it has commenced an investigation of Alto Neuroscience, Inc. concerning

Alto Neuroscience, Valuation on November 4, 2024

It is possible to determine the worth of Alto Neuroscience, on a given historical date. On November 4, 2024 Alto was worth 3.94 at the beginning of the trading date compared to the closed value of 3.71. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Alto Neuroscience, stock. Still, in general, we apply an absolute valuation method to find Alto Neuroscience,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alto Neuroscience, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Alto Neuroscience,'s related companies.
 Open High Low Close Volume
  3.92    4.07    3.89    3.98    411,880  
11/04/2024
  3.94    3.95    3.68    3.71    621,940  
  3.69    3.83    3.61    3.75    497,515  
Backtest Alto Neuroscience,  |  Alto Neuroscience, History  |  Alto Neuroscience, Valuation   PreviousNext  
Open Value
3.94
3.71
Closing Value
33.91
Upside

Alto Neuroscience, Trading Date Momentum on November 4, 2024

On November 05 2024 Alto Neuroscience, was traded for  3.75  at the closing time. The top price for the day was 3.83  and the lowest listed price was  3.61 . The trading volume for the day was 497.5 K. The trading history from November 5, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 1.08% . The overall trading delta against the current closing price is 22.37% .

Alto Neuroscience, Fundamentals Correlations and Trends

By evaluating Alto Neuroscience,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Alto Neuroscience,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Alto financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Alto Neuroscience, Stock history

Alto Neuroscience, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alto is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alto Neuroscience, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alto Neuroscience, stock prices may prove useful in developing a viable investing in Alto Neuroscience,
Last ReportedProjected for Next Year
Common Stock Shares Outstanding30.9 M28.6 M

Alto Neuroscience, Quarterly Net Working Capital

185.57 Million

Alto Neuroscience, Stock Technical Analysis

Alto Neuroscience, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Alto Neuroscience, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Alto Neuroscience, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Alto Neuroscience, Period Price Range

Low
November 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Alto Neuroscience, cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Alto Neuroscience, November 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Alto Neuroscience, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alto Neuroscience, shares will generate the highest return on investment. By undertsting and applying Alto Neuroscience, stock market strength indicators, traders can identify Alto Neuroscience, entry and exit signals to maximize returns

Alto Neuroscience, Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Alto Neuroscience,'s price direction in advance. Along with the technical and fundamental analysis of Alto Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alto to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Alto Neuroscience, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alto Neuroscience,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alto Neuroscience, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alto Neuroscience, Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alto Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.85)
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.